This site is intended for healthcare professionals only
LoginRegister
Fake Drug Unit Operator Sentenced to 7-Year Jail TermUnqualified pharmacists to face 1 year jail, Rs 5 lakh fine: National Pharmacy Commission Bill 2023...
Pharma Industry has potential to grow to USD 200 billion in value terms by 2030: Pharma SecyPharma Industry has potential to grow to USD 200 billion in value terms by 2030: Pharma Secy
Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye DeviceMedtronic gets USFDA approval for minimally invasive device to treat hypertension
AstraZenecas Proposal to Increase Sample Size in Zibotentan-Dapagliflozin Global Trial Gets SEC NodAstraZeneca Imfinzi plus chemotherapy approved in China for locally advanced or metastatic biliary...
Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE MarkRoche subcutaneous injection of Tecentriq recommended by EU CHMP for multiple cancer types
Bayer recalls one lot of cancer drug Vitrakvi in US over microbial contaminationBayer recalls one lot of cancer drug Vitrakvi in US over microbial contamination
IVF specialist moves Delhi HC against blanket ban on frozen embryo adoption, court seeks centres responseCentre gets 8 weeks ultimatum from Delhi HC to frame policy on online sale of medicines
Truqap plus Faslodex approved in US for advanced HR-positive breast cancer: AstraZenecaTruqap plus Faslodex approved in US for advanced HR-positive breast cancer: AstraZeneca
Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspectionUSFDA concludes inspection at Aurobindo Pharma arm Unit I, III with zero observations
Lupin gets USFDA approval for Ganirelix Acetate InjectionLupin gets USFDA approval for Ganirelix Acetate Injection
Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for EnhertuRoche unveils Elecsys Anti-HEV IgM, Elecsys Anti-HEV IgG immunoassays for hepatitis E virus...
AstraZeneca Pharma India plans to sell Bengaluru facilityAstraZeneca Pharma India plans to sell Bengaluru facility
X